| Contact Levi & Korsinsky by July 7, 2025 Deadline to Join Class Action Against West Pharmaceutical Services, Inc. (WST) |
NEW YORK, May 16, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc." or the "Company") (NYSE: WST) of a class action securities lawsuit. |
globenewswire.com |
2025-05-16 17:14:00 |
Czytaj oryginał (ang.) |
| Lost Money on West Pharmaceutical Services, Inc. (WST)? Contact Levi & Korsinsky Before July 7, 2025 to Join Class Action |
NEW YORK, NY / ACCESS Newswire / May 16, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=148915&wire=1&utm_campaign=12 or contact Joseph E. Levi, Esq. |
accessnewswire.com |
2025-05-16 15:30:00 |
Czytaj oryginał (ang.) |
| Did You Lose Money on West Pharmaceutical Services, Inc. (WST)? Levi & Korsinsky Urges Investors to Act Before July 7, 2025 |
NEW YORK, NY / ACCESS Newswire / May 16, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=148907&wire=1&utm_campaign=28 or contact Joseph E. Levi, Esq. |
accessnewswire.com |
2025-05-16 14:30:00 |
Czytaj oryginał (ang.) |
| WST Investors Have Opportunity to Lead West Pharmaceutical Services, Inc. Securities Fraud Lawsuit with the Schall Law Firm |
LOS ANGELES , May 16, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against West Pharmaceutical Services, Inc. ("West" or "the Company") (NYSE: WST) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 16, 2023 and February 12, 2025, inclusive (the "Class Period"), are encouraged to contact the firm before July 7, 2025. |
prnewswire.com |
2025-05-16 14:08:00 |
Czytaj oryginał (ang.) |
| Securities Class Action Lawsuit Filed Against West Pharmaceutical Services, Inc. (WST) - Levi & Korsinsky Represents Shareholders |
NEW YORK, NY / ACCESS Newswire / May 16, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=148812&wire=1&utm_campaign=13 or contact Joseph E. Levi, Esq. |
accessnewswire.com |
2025-05-16 13:15:00 |
Czytaj oryginał (ang.) |
| INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST |
NEW YORK CITY, NY / ACCESS Newswire / May 16, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against West Pharmaceutical Services, Inc. ("West" or the "Company") (NYSE:WST). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. |
accessnewswire.com |
2025-05-16 13:00:00 |
Czytaj oryginał (ang.) |
| Class Action Lawsuit Alert: Levi & Korsinsky Reminds West Pharmaceutical Services, Inc. (WST) Investors of July 7, 2025 Deadline |
NEW YORK, NY / ACCESS Newswire / May 16, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=148797&wire=1&utm_campaign=16 or contact Joseph E. Levi, Esq. |
accessnewswire.com |
2025-05-16 11:15:00 |
Czytaj oryginał (ang.) |
| WST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that West Pharmaceutical Services, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit! |
NEW YORK, NY / ACCESS Newswire / May 16, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against West Pharmaceutical Services, Inc. ("West" or "the Company") (NYSE:WST) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired West securities between February 16, 2023 and February 12, 2025, both dates inclusive (the "Class Period"). |
accessnewswire.com |
2025-05-16 11:00:00 |
Czytaj oryginał (ang.) |
| Levi & Korsinsky Reminds West Pharmaceutical Services, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 7, 2025 - WST |
NEW YORK , May 16, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc." or the "Company") (NYSE: WST) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of West Pharmaceutical Services, Inc. investors who were adversely affected by alleged securities fraud between February 16, 2023 and February 12, 2025. |
prnewswire.com |
2025-05-16 09:45:00 |
Czytaj oryginał (ang.) |
| Shareholders of West Pharmaceutical Services, Inc. Should Contact The Gross Law Firm Before July 7, 2025 to Discuss Your Rights – WST |
NEW YORK, May 15, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of West Pharmaceutical Services, Inc. (NYSE: WST). |
globenewswire.com |
2025-05-15 17:57:00 |
Czytaj oryginał (ang.) |
| Levi & Korsinsky Notifies West Pharmaceutical Services, Inc. (WST) Shareholders of Class Action Lawsuit and July 7, 2025 Deadline |
NEW YORK, NY / ACCESS Newswire / May 15, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=148717&wire=1&utm_campaign=15 or contact Joseph E. Levi, Esq. |
accessnewswire.com |
2025-05-15 16:30:00 |
Czytaj oryginał (ang.) |
| Deadline Approaching: West Pharmaceutical Services, Inc. (WST) Investors Who Lost Money Urged To Contact Law Offices of Howard G. Smith |
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith reminds investors of the upcoming July 7, 2025 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased West Pharmaceutical Services, Inc. (“West” or the “Company”) (NYSE: WST) common stock between February 16, 2023 and February 12, 2025, inclusive (the “Class Period”). IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN WEST PHARMACEUTICAL SERVICES, INC. (WST), CONTACT THE LAW OFFICES OF HOWARD G. S. |
businesswire.com |
2025-05-15 16:00:00 |
Czytaj oryginał (ang.) |
| Investors in West Pharmaceutical Services, Inc. (WST): Protect Your Rights - Contact Levi & Korsinsky Before July 7, 2025 |
NEW YORK, NY / ACCESS Newswire / May 15, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=148698&wire=1&utm_campaign=11 or contact Joseph E. Levi, Esq. |
accessnewswire.com |
2025-05-15 15:00:00 |
Czytaj oryginał (ang.) |
| Securities Lawsuit Alert: West Pharmaceutical Services, Inc. (WST) - Contact Levi & Korsinsky Before July 7, 2025 |
NEW YORK, NY / ACCESS Newswire / May 15, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=148629&wire=1&utm_campaign=3 or contact Joseph E. Levi, Esq. |
accessnewswire.com |
2025-05-15 11:15:00 |
Czytaj oryginał (ang.) |
| WST SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that West Pharmaceutical Services, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! |
NEW YORK, NY / ACCESS Newswire / May 15, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against West Pharmaceutical Services, Inc. ("West" or "the Company") (NYSE:WST) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired West securities between February 16, 2023 and February 12, 2025, both dates inclusive (the "Class Period"). |
accessnewswire.com |
2025-05-15 11:00:00 |
Czytaj oryginał (ang.) |
| WST LAWSUIT ALERT: The Gross Law Firm Notifies West Pharmaceutical Services, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline |
NEW YORK , May 15, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of West Pharmaceutical Services, Inc. (NYSE: WST). Shareholders who purchased shares of WST during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. |
prnewswire.com |
2025-05-15 09:45:00 |
Czytaj oryginał (ang.) |
| Lost Money on West Pharmaceutical Services, Inc. (WST)? Join Class Action Before July 7, 2025 – Contact Levi & Korsinsky |
NEW YORK, NY / ACCESS Newswire / May 14, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=148589&wire=1&utm_campaign=23 or contact Joseph E. Levi, Esq. |
accessnewswire.com |
2025-05-15 01:20:00 |
Czytaj oryginał (ang.) |
| Contact Levi & Korsinsky by July 7, 2025 to Join Class Action Against West Pharmaceutical Services, Inc. (WST) |
NEW YORK, NY / ACCESS Newswire / May 14, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=148568&wire=1&utm_campaign=10 or contact Joseph E. Levi, Esq. |
accessnewswire.com |
2025-05-14 22:45:00 |
Czytaj oryginał (ang.) |
| WST Investors Have Opportunity to West Pharmaceutical Services, Inc. Securities Fraud Lawsuit |
NEW YORK , May 14, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of purchasers of common stock of West Pharmaceutical Services, Inc. (NYSE: WST) between February 16, 2023 and February 12, 2025, both dates inclusive (the "Class Period"). A class action lawsuit has already been filed. |
prnewswire.com |
2025-05-14 22:27:00 |
Czytaj oryginał (ang.) |
| Lost Money on West Pharmaceutical Services, Inc. (WST)? Join Class Action Before July 7, 2025 - Contact Levi & Korsinsky |
NEW YORK, NY / ACCESS Newswire / May 14, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=148560&wire=1&utm_campaign=23 or contact Joseph E. Levi, Esq. |
accessnewswire.com |
2025-05-14 21:45:00 |
Czytaj oryginał (ang.) |
| Levi & Korsinsky Investigates Possible Securities Fraud Violations by West Pharmaceutical Services, Inc. (WST) |
NEW YORK, NY / ACCESS Newswire / February 27, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc.") (NYSE:WST) concerning possible violations of federal securities laws. On February 12, 2025, West reported positive 4Q 2024 financial results but announced full year 2025 guidance that was well below analysts' expectations. |
accessnewswire.com |
2025-02-27 09:30:00 |
Czytaj oryginał (ang.) |
| West Pharmaceutical Services, Inc. Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud Allegations - WST |
NEW YORK, NY / ACCESS Newswire / February 26, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc.") (NYSE:WST) concerning possible violations of federal securities laws. On February 12, 2025, West reported positive 4Q 2024 financial results but announced full year 2025 guidance that was well below analysts' expectations. |
accessnewswire.com |
2025-02-26 09:45:00 |
Czytaj oryginał (ang.) |
| West Pharmaceutical Services, Inc. (WST) Investors with Losses are Urged to Contact Levi & Korsinsky to Discuss Their Rights |
NEW YORK, NY / ACCESS Newswire / February 25, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc.") (NYSE:WST) concerning possible violations of federal securities laws. On February 12, 2025, West reported positive 4Q 2024 financial results but announced full year 2025 guidance that was well below analysts' expectations. |
accessnewswire.com |
2025-02-25 09:30:00 |
Czytaj oryginał (ang.) |
| West Pharmaceutical Services, Inc. (WST) Investors with Losses are Urged to Contact Levi & Korsinsky to Discuss Their Rights |
NEW YORK, NY / ACCESS Newswire / February 24, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc.") (NYSE:WST) concerning possible violations of federal securities laws. On February 12, 2025, West reported positive 4Q 2024 financial results but announced full year 2025 guidance that was well below analysts' expectations. |
accessnewswire.com |
2025-02-24 09:30:00 |
Czytaj oryginał (ang.) |
| West Pharmaceutical Services, Inc. (WST) Shareholders May Have Been Affected by Fraud - Levi & Korsinsky Investigates |
NEW YORK, NY / ACCESS Newswire / February 21, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc.") (NYSE:WST) concerning possible violations of federal securities laws. On February 12, 2025, West reported positive 4Q 2024 financial results but announced full year 2025 guidance that was well below analysts' expectations. |
accessnewswire.com |
2025-02-21 17:30:00 |
Czytaj oryginał (ang.) |
| West Announces Second-Quarter Dividend |
EXTON, Pa. , Feb. 20, 2025 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced today that the Company's Board of Directors has approved a second-quarter 2025 dividend of $0.21 per share. The dividend will be paid on May 7, 2025, to shareholders of record as of April 30, 2025. |
prnewswire.com |
2025-02-20 18:30:00 |
Czytaj oryginał (ang.) |
| West Pharmaceuticals Takes A Plunge, But May Still Offer Opportunities |
The price of West Pharmaceutical Services plunged over 38% after it released its Q4 and FY 2024 earnings results on February 13. Shareholders, mostly institutional investors apparently, did not like the bottom-line results nor the uninspiring guidance for 2025. Still, West should not be overlooked, and there may be opportunities if the share price continues to rebound after a market overreaction. |
seekingalpha.com |
2025-02-17 03:15:53 |
Czytaj oryginał (ang.) |
| Final Trade: WST, BTC, GLD, ALT |
The final trades of the day with the Fast Money traders. |
youtube.com |
2025-02-14 20:32:53 |
Czytaj oryginał (ang.) |
| Is WST Stock Undervalued At $200? |
West Pharmaceutical Services, a global provider of solutions for drugs, biologics, gene therapies, and consumer healthcare products, recently announced its Q4 results, surpassing analysts' expectations for both revenue and earnings. The company reported sales of $749 million and adjusted earnings per share of $1.82, compared to $740 million and $1.73, respectively. |
forbes.com |
2025-02-14 10:46:31 |
Czytaj oryginał (ang.) |
| West Pharmaceutical Services, Inc. (WST) Q4 2024 Earnings Call Transcript |
West Pharmaceutical Services, Inc. (NYSE:WST ) Q4 2024 Earnings Conference Call February 13, 2025 9:00 AM ET Company Participants John Sweeney - Vice President of Investor Relations Eric Green - Chairman, President & Chief Executive Officer Bernard Birkett - Senior Vice President & Chief Financial Officer Conference Call Participants Michael Ryskin - BofA Global Research Lawrence Solow - CJS Securities Patrick Donnelly - Citigroup Inc. Paul Knight - KeyBanc Capital Markets Matthew Larew - William Blair & Company Justin Bowers - Deutsche Bank David Windley - Jefferies Jacob Johnson - Stephens Inc. Operator Thank you for standing by and welcome to West Pharmaceuticals Fourth Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode. |
seekingalpha.com |
2025-02-13 17:50:14 |
Czytaj oryginał (ang.) |
| West Pharma's stock tanks 33% to lead S&P 500 decliners as guidance misses by a wide margin |
West Pharmaceutical Services Inc.'s stock tumbled 33% Thursday, to lead S&P 500 decliners, after the manufacturer of injectable-pharmaceutical packaging and delivery systems offered guidance for 2025 that was well below expectations. |
marketwatch.com |
2025-02-13 15:49:00 |
Czytaj oryginał (ang.) |
| West Pharmaceutical Stock Sinks On Weaker Than Expected 2025 Guidance |
On Thursday, West Pharmaceutical Services, Inc. WST reported a fourth-quarter adjusted EPS of $1.82, beating the consensus of $1.72. |
benzinga.com |
2025-02-13 14:51:55 |
Czytaj oryginał (ang.) |
| West Pharmaceutical forecasts 2025 results below expectations, shares drop |
West Pharmaceutical Services forecast full-year profit and revenue below Wall Street estimates on Thursday due to a strong dollar and as the medical equipment maker's clients reduce inventory levels, sending its shares down 18% premarket. |
reuters.com |
2025-02-13 10:25:06 |
Czytaj oryginał (ang.) |
| West Pharmaceutical Services (WST) Surpasses Q4 Earnings and Revenue Estimates |
West Pharmaceutical Services (WST) came out with quarterly earnings of $1.82 per share, beating the Zacks Consensus Estimate of $1.75 per share. This compares to earnings of $1.83 per share a year ago. |
zacks.com |
2025-02-13 10:12:23 |
Czytaj oryginał (ang.) |
| West Announces Fourth-Quarter and Full-Year 2024 Results |
- Conference Call Scheduled for 9 a.m. EDT Today - EXTON, Pa. |
prnewswire.com |
2025-02-13 08:00:00 |
Czytaj oryginał (ang.) |
| Will Segmental Performance Drive West Pharmaceutical's Q4 Earnings? |
West Pharmaceutical Services WST is scheduled to release fourth-quarter 2024 results on Feb. 13, before the opening bell. In the last reported quarter, the company delivered an earnings beat of 22.52%. |
zacks.com |
2025-02-10 16:41:24 |
Czytaj oryginał (ang.) |
| West to Host Fourth-Quarter and Full-Year 2024 Conference Call |
EXTON, Pa. , Jan. 30, 2025 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), global leader in innovative solutions for injectable drug administration, today announced that it will release fourth-quarter and full-year 2024 financial results before the market opens on Thursday, February 13, 2025, and will follow with a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time. |
prnewswire.com |
2025-01-30 08:00:00 |
Czytaj oryginał (ang.) |
| West Announces First-Quarter Dividend |
EXTON, Pa. , Jan. 28, 2025 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced today that the Company's Board of Directors has approved a first-quarter 2025 dividend of $0.21 per share. The dividend will be paid on February 11, 2025, to shareholders of record as of February 7, 2025. |
prnewswire.com |
2025-01-28 14:00:00 |
Czytaj oryginał (ang.) |
| West Introduces Daikyo PLASCAP® RUV Closures in New Nested Format at Pharmapack |
EXTON, Pa. , Jan. 22, 2025 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced the introduction of Daikyo PLASCAP® Ready-to-Use Validated (RUV) closures in a new nested format available in multiple configurations at this year's Pharmapack event in Paris, France. This marks West's latest product offering supporting the needs of advanced therapies, one of the fastest growing areas, driven by continued innovation in cell and gene therapy treatments. |
prnewswire.com |
2025-01-22 08:00:00 |
Czytaj oryginał (ang.) |
| Reasons to Hold West Pharmaceutical Stock in Your Portfolio Now |
WST continues to gain momentum due to its strength in the Pharma market unit. However, the decline across its Generics and Biologics business units is concerning. |
zacks.com |
2025-01-20 11:46:11 |
Czytaj oryginał (ang.) |
| LH vs. WST: Which Stock Is the Better Value Option? |
Investors interested in Medical - Dental Supplies stocks are likely familiar with Labcorp (LH) and West Pharmaceutical Services (WST). But which of these two companies is the best option for those looking for undervalued stocks? |
zacks.com |
2025-01-03 14:51:11 |
Czytaj oryginał (ang.) |
| Reasons to Hold West Pharmaceutical Stock in Your Portfolio Now |
WST continues to gain momentum due to its strength in the Pharma market unit. However, the decline across its Generics and Biologics business units is concerning. |
zacks.com |
2024-12-20 11:06:26 |
Czytaj oryginał (ang.) |
| West Elects New Director to the Board |
EXTON, Pa. , Dec. 11, 2024 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced the Company's Board of Directors has elected Janet Haugen as its newest member. With the addition of Ms. |
prnewswire.com |
2024-12-11 08:00:00 |
Czytaj oryginał (ang.) |
| 3 Dividend Gems You Didn't Know Could Build Lasting Wealth |
Over the next 25 years, $124 trillion in inheritances will be transferred, reshaping wealth distribution and offering new investment opportunities for younger generations. Three dividend growth companies on my watch list have impressive potential, enjoying strong secular growth. While these companies may not be “mainstream,” their solid business models and growth prospects make them excellent picks for long-term investors. |
seekingalpha.com |
2024-12-08 09:30:00 |
Czytaj oryginał (ang.) |
| MMSI or WST: Which Is the Better Value Stock Right Now? |
Investors looking for stocks in the Medical - Dental Supplies sector might want to consider either Merit Medical (MMSI) or West Pharmaceutical Services (WST). But which of these two stocks presents investors with the better value opportunity right now? |
zacks.com |
2024-11-29 14:46:27 |
Czytaj oryginał (ang.) |
| Reasons to Hold West Pharmaceutical Stock in Your Portfolio Now |
WST continues to gain momentum due to its strength in the Pharma market unit. However, decline across its Generics and Biologics business units is concerning. |
zacks.com |
2024-11-19 11:26:08 |
Czytaj oryginał (ang.) |
| Final Trade: West Pharma, Cameco, iShares Biotechnology ETF and Applied Digital Corp |
The final trades of the day with the Fast Money traders. |
youtube.com |
2024-11-15 20:54:37 |
Czytaj oryginał (ang.) |
| 17 Upcoming Dividend Increases |
This week, 17 companies with an average dividend increase of 8.3% are highlighted, emphasizing consistent dividend growth and outperforming benchmarks. My investment strategy focuses on buying, holding, and adding companies with consistent dividend increases and superior performance compared to benchmarks. The list is created using data from the "U.S. Dividend Champions" spreadsheet and NASDAQ, featuring companies with at least five years of dividend growth. |
seekingalpha.com |
2024-11-07 01:03:07 |
Czytaj oryginał (ang.) |
| West to Participate in Upcoming Investor Conferences |
EXTON, Pa. , Oct. 29, 2024 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will present at the following conferences: UBS Global Healthcare Conference in Rancho Pablos Verdes, California, on November 12, 2024 at 3:30 PM PST Jefferies Healthcare Conference in London, UK on Tuesday, November 19, 2024 at 1:00 PM GMT Stephens Annual Investment Conference in Nashville, TN on Thursday, November 21, 2024 at 10:00 AM CST A live audio webcast of these events will be available in the "Investors" section of the Company's website at www.westpharma.com. Replay of the webcasts will be available for approximately 90 days after the events. |
prnewswire.com |
2024-10-29 08:00:00 |
Czytaj oryginał (ang.) |
| The Zacks Analyst Blog The Gorman-Rupp, Kontoor Brands, Kontoor Brands and Standex International |
The Gorman-Rupp, Kontoor Brands, Kontoor Brands and Standex International are included in this Analyst Blog. |
zacks.com |
2024-10-29 07:35:18 |
Czytaj oryginał (ang.) |
| Buy These 4 Stocks With New Dividend Hikes Amid Market Volatility |
Stocks like GRC, KTB, WST and SXI recently announced dividend hikes. |
zacks.com |
2024-10-28 17:01:13 |
Czytaj oryginał (ang.) |
| West Pharmaceutical Services, Inc. (WST) Q3 2024 Earnings Call Transcript |
West Pharmaceutical Services, Inc. (NYSE:WST ) Q3 2024 Results Earnings Conference Call October 24, 2024 9:00 AM ET Company Participants John Sweeney - Vice President, Investor Relations Eric Green - Chairman, President and Chief Executive Officer Bernard Birkett - Senior Vice President, Chief Financial Officer Conference Call Participants Jacob Johnson - Stephens Inc. Lawrence Solow - CJS Securities Michael Ryskin - BofA Global Research David Windley - Jefferies Matthew Larew - William Blair & Company Justin Bowers - Deutsche Bank Thomas DeBourcy - Nephron Research Operator Good day and thank you for standing by. Welcome to the Q3 2024 West Pharmaceutical Services Earnings Conference Call. |
seekingalpha.com |
2024-10-24 19:02:04 |
Czytaj oryginał (ang.) |
| West Pharmaceutical's Q3 Performance Shows Rising Demand For Syringes, Company Boosts Annual Forecast And Dividend |
On Thursday, West Pharmaceutical Services, Inc. WST reported adjusted EPS of $1.85, down from $2.16 a year ago, beating the consensus of $1.50. |
benzinga.com |
2024-10-24 17:09:38 |
Czytaj oryginał (ang.) |
| West Pharmaceutical Stock Gains on Q3 Earnings Beat & Raised Guidance |
WST's third-quarter results reflect a recovery in the Proprietary Products segment following elevated customer destocking, hurting sales in the second quarter. |
zacks.com |
2024-10-24 16:10:19 |
Czytaj oryginał (ang.) |
| West Pharmaceutical Services (WST) Tops Q3 Earnings and Revenue Estimates |
West Pharmaceutical Services (WST) came out with quarterly earnings of $1.85 per share, beating the Zacks Consensus Estimate of $1.51 per share. This compares to earnings of $2.16 per share a year ago. |
zacks.com |
2024-10-24 12:11:16 |
Czytaj oryginał (ang.) |
| West Pharmaceutical raises annual profit forecast on demand for medical supplies |
West Pharmaceutical Services raised its annual profit forecast on Thursday, after beating Wall Street estimates for quarterly revenue and profit, banking on rising demand for cartridges and syringes used to manufacture injectable therapies. |
reuters.com |
2024-10-24 10:46:00 |
Czytaj oryginał (ang.) |
| West Announces Third-Quarter 2024 Results, Increases Fiscal Year 2024 Guidance and Declares Fourth-Quarter 2024 Dividend |
- Conference Call Scheduled for 9 a.m. EDT Today - EXTON, Pa. |
prnewswire.com |
2024-10-24 10:00:00 |
Czytaj oryginał (ang.) |
| West to Present on Large Volume Delivery Systems, Administration and Transfer Devices, and Prefillable Syringe Component Expertise at the PDA Conference |
EXTON, Pa. , Oct. 22, 2024 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced participation in the 2024 PDA Universe of Pre-Filled Syringes and Injection Devices Conference in Phoenix, AZ to showcase its leadership and expertise on industry challenges and trends in packaging and containment. "With the rise of biologic drugs, injectables are the fastest growing drug segment today, bringing with it new challenges of complex molecules and treatment requirements," says Atul Patel, Vice President, Delivery Devices at West. |
prnewswire.com |
2024-10-22 10:00:00 |
Czytaj oryginał (ang.) |
| What's in Store for West Pharmaceutical in Q3 Earnings? |
WST's third-quarter 2024 results are likely to reflect weakness in its Proprietary Products business. Unfavorable currency movements might have hurt the top and bottom lines. |
zacks.com |
2024-10-21 14:50:18 |
Czytaj oryginał (ang.) |
| Earnings Preview: West Pharmaceutical Services (WST) Q3 Earnings Expected to Decline |
West Pharmaceutical (WST) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. |
zacks.com |
2024-10-17 15:06:05 |
Czytaj oryginał (ang.) |